SABiosciences
-
Fluidigm and SABiosciences Introduce Gene Expression Assays
Fluidigm Corporation and SABiosciences have teamed up to create over 100 pathway-focused gene expression panels validated for real-time Polymerase Chain Reaction (PCR) analysis on the Fluidigm BioMark System for Genetic Analysis. These gene expre…
SABiosciences | 30 April 2010
-
Qiagen to Acquire SABiosciences
Qiagen has signed an agreement to acquire SABiosciences Corporation, a privately-held developer and manufacturer of disease- and pathway-focused Polymerase Chain Reaction (PCR) assay panels. The transaction is valued at US$90 million in cash (subject…
SABiosciences | 27 November 2009
